Literature DB >> 18496559

Improving minimal residual disease detection in precursor B-ALL based on immunoglobulin-kappa and heavy-chain gene rearrangements.

R Sutton, A Y Bahar, E Kwan, J E Giles, N C Venn, S Tran, N Hackenberg, L Dalla Pozza, G M Marshall, M Haber, V H J van der Velden, M D Norris.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18496559     DOI： 10.1038/leu.2008.121

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  3 in total

1.  Sensitive and specific measurement of minimal residual disease in acute lymphoblastic leukemia.

Authors:  Alexander A Morley; Sue Latham; Michael J Brisco; Pamela J Sykes; Rosemary Sutton; Elizabeth Hughes; Vicki Wilczek; Bradley Budgen; Katrina van Zanten; Bryone J Kuss; Nicola C Venn; Murray D Norris; Catherine Crock; Colin Storey; Tamas Revesz; Keith Waters
Journal:  J Mol Diagn       Date:  2009-03-26       Impact factor: 5.568

2.  Improving the identification of high risk precursor B acute lymphoblastic leukemia patients with earlier quantification of minimal residual disease.

Authors:  Mawar Karsa; Luciano Dalla Pozza; Nicola C Venn; Tamara Law; Rachael Shi; Jodie E Giles; Anita Y Bahar; Shamira Cross; Daniel Catchpoole; Michelle Haber; Glenn M Marshall; Murray D Norris; Rosemary Sutton
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

3.  Heterogeneity in mechanisms of emergent resistance in pediatric T-cell acute lymphoblastic leukemia.

Authors:  Babasaheb D Yadav; Amy L Samuels; Julia E Wells; Rosemary Sutton; Nicola C Venn; Katerina Bendak; Denise Anderson; Glenn M Marshall; Catherine H Cole; Alex H Beesley; Ursula R Kees; Richard B Lock
Journal:  Oncotarget       Date:  2016-09-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.